Post Profile

New Non-Invasive Assay May Improve Surveillance of Heart and Other Solid-Organ Transplants

Patients who have received a solid organ transplant require lifelong immunosuppressive therapy. The threat of transplant rejection due to insufficient drug therapy must be balanced against increased risks of infections and cancer from excessive immunosuppression. A significant unmet need exists for non-invasive diagnostic tools to monitor transplant recipients, especially for early detection of active injury and rejection.
read more


Related Posts

Can Transplant Recipients Be Weaned Off Their Immunosuppresive Drugs?

Health : Medical News Today

Transplant surgeons live in the hope that one day they will be able to wean at least some of their patients off the immunosuppressive drugs that must be taken to prevent rejection of a transplanted organ. A team of researchers led b...

Assessing rejection risk for heart transplant patients

Health : Time: Healthland

A blood test may offer heart transplant patients a less invasive way to assess rejection risk, according to a study published online today in the New England Journal of Medicine. As with most organ donations, heart transplants can p...

Researchers Link Organ Transplant Drug to Rise in Rare Lymphoma

Health : Newswise Medical News

A study led by Johns Hopkins researchers has linked the immunosuppressive drug mycophenolate mofetil (MMF) to an increased risk of central nervous system (CNS) lymphoma in solid organ transplant patients

Recipients of Organ Transplants at Increased Risk For Broad Range of Cancers

Health : Newswise Medical News

Patients who have received a solid organ transplant, such as kidney, liver, heart or lung, have an overall cancer risk that is double that of the general population, with an increased risk for many different types of malignancies, a...

Immunosuppressive Drugs Combo Led To Less Organ Rejection, Better Kidney Health After Transplant

Health : Medical News Today

For the thousands of patients who receive kidney transplants in the United States each year, preventing organ rejection without compromising other aspects of health requires a delicate balance of medications. Immunosuppresive drugs ...


Copyright © 2016 Regator, LLC